Disparities in pediatric acute myeloid leukemia (AML) clinical trial enrollment

References

• Strahlendorf C, Pole JD, Barber R, et al. Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study. Br J Cancer. 2018;118:744–749.
   PubMed Web of Science ®Google Scholar
• Stiller CA, Draper GJ. Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch Dis Child. 1989;64:657–661.
   PubMed Web of Science ®Google Scholar
• Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J. Natl. Cancer Inst. 1996;88:812–816.
   PubMed Web of Science ®Google Scholar
• Parsons HM, Harlan LC, Seibel NL, et al. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? J Clin Oncol. 2011;29:4045–4053.
   PubMed Web of Science ®Google Scholar
• Krailo MD, Bernstein L, Sullivan-Halley J, et al. Patterns of enrollment on cooperative group studies. An analysis of trends from the Los Angeles County Cancer Surveillance Program. Cancer. 1993;71:3325–3330.
   PubMed Web of Science ®Google Scholar
• Bleyer WA, Tejeda HA, Murphy SB, et al. Equal participation of minority patients in U.S. national pediatric cancer clinical trials. J Pediatr Hematol Oncol. 1997;19:423–427.
   PubMed Web of Science ®Google Scholar
• Aristizabal P, Singer J, Cooper R, et al. Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities. Pediatr Blood Cancer. 2015;62:1337–1344.
   PubMed Web of Science ®Google Scholar
• Lund MJ, Eliason MT, Haight AE, et al. Racial/ethnic diversity in children's oncology clinical trials: ten years later. Cancer. 2009;115:3808–3816.
   PubMed Web of Science ®Google Scholar
• Pole JD, Barber R, Bergeron R-É, et al. Most children with cancer are not enrolled on a clinical trial in Canada: a population-based study. BMC Cancer. 2017;17:402.
   PubMed Web of Science ®Google Scholar
• Aplenc R, Fisher BT, Huang YS, et al. Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children Oncology Group. Pharmacoepidemiol Drug Saf. 2012;21:37–43.
   PubMed Web of Science ®Google Scholar
• Miller VA, Nelson RM. Factors related to voluntary parental decision-making in pediatric oncology. Pediatrics. 2012;129:903–909.
   PubMed Web of Science ®Google Scholar
• Kavcic M, Fisher BT, Torp K, et al. Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database. Pediatr Blood Cancer. 2013;60:508–511.
   PubMed Web of Science ®Google Scholar
• Creutzig U, Zimmermann M, Reinhardt D, et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004;22:4384–4393.
   PubMed Web of Science ®Google Scholar
• Cheng S, Pole JD, Sung L. Early deaths in pediatric acute leukemia: a population-based study. Leuk Lymphoma. 2014;55:1518–1522.
   PubMed Web of Science ®Google Scholar
• Maude SL, Fitzgerald JC, Fisher BT, et al. Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States. Pediatr. Crit Care Med. 2014;15:112–120.
   Web of Science ®Google Scholar
• Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720–2726.
   PubMed Web of Science ®Google Scholar
• Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006;3:e19.
   PubMed Web of Science ®Google Scholar
• Rivers D, August EM, Sehovic I, et al. A systematic review of the factors influencing African Americans’ participation in cancer clinical trials. Contemp Clin Trials. 2013;35:13–32.
   PubMed Web of Science ®Google Scholar
• Durant RW, Wenzel JA, Scarinci IC, et al. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer. 2014;120:1097–1105.
   PubMed Web of Science ®Google Scholar
• Aplenc R, Alonzo TA, Gerbing RB, et al. Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group. Blood. 2006;108:74–80.
   PubMed Web of Science ®Google Scholar
• Winestone LE, Getz KD, Miller TP, et al. The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia. Am J Hematol. 2017;92:141–148.
   PubMed Web of Science ®Google Scholar
• Gramatges MM, Deshpande A, Lupo PJ. Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia. Pediatr Blood Cancer. 2017;64:e26487.
   Web of Science ®Google Scholar
• Unger JM, Hershman DL, Albain KS, et al. Patient income level and cancer clinical trial participation. J Clin Oncol. 2013;31:536–542.
   PubMed Web of Science ®Google Scholar
• Gross CP, Filardo G, Mayne ST, et al. The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer. 2005;103:483–491.
   PubMed Web of Science ®Google Scholar
• Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109–2117.
   PubMed Web of Science ®Google Scholar
• Bleyer WA, Tejeda H, Murphy SB, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health. 1997;21:366–373.
   PubMed Web of Science ®Google Scholar
• Thomas SM, Malvar J, Tran H, et al. A prospective, observational cohort study comparing cancer clinical trial availability and enrollment between early adolescents/young adults and children. Cancer. 2018;124:983–990.
   PubMed Web of Science ®Google Scholar
• Shochat SJ, Fremgen AM, Murphy SB, et al. Childhood cancer: patterns of protocol participation in a national survey. CA Cancer J Clin. 2001;51:119–130.
   PubMed Web of Science ®Google Scholar
• Liu L, Krailo M, Reaman GH, et al. L, Surveillance EaERCCLG. Childhood cancer patients' access to cooperative group cancer programs: a population-based study. Cancer. 2003;97:1339–1345.
   PubMed Web of Science ®Google Scholar
• Jacobs SR, Weiner BJ, Reeve BB, et al. Organizational and physician factors associated with patient enrollment in cancer clinical trials. Clinical Trials. 2014;11:565–575.
   PubMed Web of Science ®Google Scholar
• Somkin CP, Ackerson L, Husson G, et al. Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting. J Oncol Pract. 2013;9:e275–e283.
   PubMedGoogle Scholar
• Peppercorn JM, Weeks JC, Cook EF, et al. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet. 2004;363:263–270.
   PubMed Web of Science ®Google Scholar
• Abu-Hejleh T, Chrischilles EA, Halfdanarson TR, et al. The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer. Am J Clin Oncol. 2016;39:126–131.
   PubMed Web of Science ®Google Scholar
• Green AL, Furutani E, Ribeiro KB, et al. Death within 1 month of diagnosis in childhood cancer: an analysis of risk factors and scope of the problem. J Clin Oncol. 2017;35:1320–1327.
   PubMed Web of Science ®Google Scholar